Advarra Announces Site IQ


Advarra has announced the launch of Site IQ. The platform builds on Advarra's experience as the provider of practice management solutions for clinical research to deliver an integrated set of site and principal investigator insights to enable smarter site selection. The Site IQ platform provides customized data analysis to help sponsors and CROs make informed decisions in their investigative site selection and feasibility processes.

Advarra Site IQ delivers insights to drive study startup by supporting protocol planning and site selection processes. Site IQ informs intelligent site selection by leveraging comprehensive data across experience, capacity, quality, performance, and patient eligibility. Data is derived from Advarra's data as well as third-party partner data. As such, Site IQ reflects insights based on actual study and performance data, not estimates or self-reported information.

Advarra Announces Site IQ

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.